Evidence map›Paper›PMID 41736870›Full record

ArticleiScience2026

Multi-omics and causal inference reveal lactylation-based osteoblast regulatory networks and drug candidates.

Ruijing Chen, Siliang Ge, Feifan Chang, Ming Chen, Yi Li, Yihui Li, Desheng You, Peifu Tang, Pengbin Yin

Abstract read
In one paragraph

Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ruijing ChenDepartment of Orthopedics, Chinese PLA General Hospital, Beijing 100853, China.
Siliang GeDepartment of Orthopedics, Chinese PLA General Hospital, Beijing 100853, China.
Feifan ChangSchool of Medicine, Nankai University, Tianjin 300071, China.
Ming ChenDepartment of Orthopedics, Chinese PLA General Hospital, Beijing 100853, China.
Yi LiDepartment of Orthopedics, Chinese PLA General Hospital, Beijing 100853, China.
Yihui LiSchool of Life Science, Bengbu Medical University, Bengbu, Anhui 233030, China.
Desheng YouSchool of Life Science, Bengbu Medical University, Bengbu, Anhui 233030, China.
Peifu TangDepartment of Orthopedics, Chinese PLA General Hospital, Beijing 100853, China.
Pengbin YinDepartment of Orthopedics, Chinese PLA General Hospital, Beijing 100853, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone loss-related disorders, driven by impaired osteoblast activity, pose a growing global health challenge, yet current anabolic therapies remain limited due to an incomplete understanding of osteoblast dysfunction. Emerging evidence suggests that lactate-derived lysine lactylation-a glycolysis-linked PTM-may regulate osteoblast differentiation and bone homeostasis, though its landscape and functional impact in osteoblasts are largely unknown. Here, we integrated multi-omics profiling, Mendelian randomization (MR), and computational modeling to investigate lactylation-mediated osteogenic regulation. Using

Indexed as

OmicsProteomicsSystems biology

Identifiers

PMID41736870
PMCPMC12927281

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.